Advances in therapy
Branded Compared with Generic Latanoprost in Glaucoma Therapy: Where Do We Stand?
Chara Tsiampali, Iordanis Vagiakis, Chrysanthi Sardeli, Anastasios G Konstas
Published: 202510.1007/s12325-025-03452-9
Abstract
In this literature review, branded and generic preserved latanoprost are compared with respect to comparative efficacy, tolerability, and physicochemical properties. Worldwide, latanoprost, a prostaglandin analogue, has evolved into the first-line me…
Preview only. Read the full abstract at the source